Business / Finance

RSS

Cegedim secures new EUR 280,000,000 5-year syndicated credit facility

Cegedim SA is pleased to announce that it has secured a new EUR 280,000,000 5-year syndicated credit facility.

15 Jun 2011

UHS intends to offer $175M of second lien senior secured PIK toggle notes due in 2015

Universal Hospital Services, Inc. today announced that it intends to offer $175 million in aggregate principal amount of its 8.50/9.25% second lien senior secured PIK toggle notes due in 2015.

15 Jun 2011

China Botanic net sales increase 56.1% to $18.9 million for second quarter 2011

China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines in China, today announced financial results for the three months ended April 30, 2011.

15 Jun 2011

Morimatsu acquires Pharmadule

Morimatsu Industry Co., Ltd., the privately owned Japanese pioneer of tank technology, has acquired Pharmadule AB of Sweden, the world leader of modular manufacturing facilities for the pharmaceutical & biopharmaceutical industries.

14 Jun 2011

Catalyst Health Solutions acquires Walgreens Health Initiatives

Catalyst Health Solutions, Inc. today announced it has completed its acquisition of Walgreens' pharmacy benefit management (PBM) subsidiary, Walgreens Health Initiatives, Inc. (WHI). Catalyst funded the transaction with a combination of cash on hand and amounts available under its credit facility.

13 Jun 2011

Aetna announces acquisition of Genworth's Medicare Supplement business

Aetna today announced that it has entered into an agreement with Genworth Financial, Inc. to acquire Genworth's Medicare Supplement business and related blocks of in-force business. Genworth is a leading provider of Medicare Supplement coverage. The business has more than 145,000 Medicare Supplement members.

13 Jun 2011

Milestone completes $13 million round of equity financing

Milestone Pharmaceuticals Inc., a cardiovascular drug development company, announces the completion of a $13 million round of equity financing.

13 Jun 2011

inVentiv Health acquires i3 CRO

inVentiv Health, Inc., offering best-in-class clinical, consulting and commercial services to the healthcare industry, today announced it has completed the acquisition of i3, a top-tier contract research organization (CRO) to the pharmaceutical, biotech and medical device industries. i3 was previously owned by Ingenix, a UnitedHealth Group company.

13 Jun 2011

Accuray acquires TomoTherapy

Accuray Incorporated announced today that it has completed its previously announced acquisition of TomoTherapy Incorporated.

13 Jun 2011

Trimeris, Synageva enter definitive merger agreement

Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, and Trimeris, Inc., announced today that they have entered into a definitive agreement under which Synageva will merge with Trimeris in an all-stock transaction.

13 Jun 2011

Servier, Cortex sign new option agreement for AMPAKINE technology

Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.

13 Jun 2011

Kurma, CRT launch BliNK Therapeutics to generate monoclonal antibodies

Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.

13 Jun 2011

IMS Health acquires Med-Vantage

IMS Health has acquired Med-Vantage, a San Francisco-based software solutions company, to further expand its presence and capabilities in the payer marketplace. Med-Vantage offers its clients a comprehensive suite of provider performance management and member engagement solutions that promote high-quality care and address the complexities of new reimbursement and care delivery models.

10 Jun 2011

PharmAthene to sell $6.5M of common stock and warrants in registered direct offering

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has entered into subscription agreements with certain institutional investors to sell approximately $6.5 million of its common stock and warrants in a registered direct offering.

10 Jun 2011

Amplifon, Rion, William Demant lead $1.4 billion Asia-Pacific retail hearing aid market

According to a new report by iData Research, the leading global authority in medical device market research, the Chinese and Indian markets for hearing devices, including retail and wholesale sales, is valued at over $1 billion and will almost double-in-value by 2017.

10 Jun 2011

Revance closes $45 million financing

Revance Therapeutics, Inc. today announced the closing of a $45 million financing led by Essex Woodlands Health Ventures and new investor, NovaQuest Capital.

10 Jun 2011

Ambit Biosciences raises $30 million through Series D-2 equity financing

Ambit Biosciences (Ambit), an emerging biopharmaceutical company engaged in the development of kinase inhibitors for the treatment of cancer and other conditions, today announced that it has completed a Series D-2 round of equity financing, raising $30 million in new capital.

10 Jun 2011